Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

2016 ◽  
Vol 17 (9) ◽  
pp. 1317-1324 ◽  
Author(s):  
Brian I Rini ◽  
Tanya B Dorff ◽  
Paul Elson ◽  
Cristina Suarez Rodriguez ◽  
Dale Shepard ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Active Surveillance ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Prospective Phase

scholarly journals Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

2013 ◽  
Vol 14 (12) ◽  
pp. 1233-1242 ◽  
Author(s):  
Brian I Rini ◽  
Bohuslav Melichar ◽  
Takeshi Ueda ◽  
Viktor Grünwald ◽  
Mayer N Fishman ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Dose Titration ◽  
Phase 2 ◽  
First Line ◽  
Double Blind ◽  
Phase 2 Trial

Patient reported outcomes in a phase 2 trial of SU11248 for metastatic renal cell carcinoma

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 8167-8167 ◽  
Author(s):  
J. Beaumont ◽  
D. Cella ◽  
J. Li ◽  
R. Motzer ◽  
B. Rini ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Patient Reported

scholarly journals Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

Cancer ◽  
2015 ◽  
Vol 121 (19) ◽  
pp. 3435-3443 ◽  
Author(s):  
M. Dror Michaelson ◽  
Rana R. McKay ◽  
Lillian Werner ◽  
Michael B. Atkins ◽  
Eliezer M. Van Allen ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Poor Risk ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document